the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Economic reforms, positive growth indicators drive foreign buying of Malaysian stocks – Tengku Zafrul

KUALA LUMPUR: The government’s dedication to economic reforms and ongoing positive growth indicators continue to drive foreign buying in Malaysia’s stock market.

Investment, Trade and Industry Minister Tengku Datuk Seri Zafrul Abdul Aziz said it reflects investors medium- and long-term confidence in the country.

“One of the reasons why the stock market is up is that it shows the confidence of our investors in the medium and long term, as well as showing that the government policies we have implemented so far are the right policies.

“At the same time, the economic overflow will be enjoyed by companies as well as the rakyat,“ he told reporters after the Malaysia Smart Manufacturing Awards 2023 event yesterday.

He said that according to the Department of Statistics Malaysia (DoSM), Malaysia’s economy is estimated to expand by 5.8 per cent in the second quarter of 2024, up from 4.2 per cent in the previous quarter.

Thus, the positive numbers will signal more inflow of foreign funds into Bursa Malaysia, domestic direct investment as well as foreign direct investment.

Tengku Zafrul was commenting on a Bloomberg article noting that Malaysia’s stock market is once again attracting global investors, attributed to the country’s good potential in artificial intelligence (AI) related services in the region.

The report said international funds turned net buyers of the equities this year as Prime Minister Datuk Seri Anwar Ibrahim implemented policies to boost foreign investments in the semiconductor industry and AI data centres.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Addressing medical inflation

Consumers are struggling as medical insurance premiums surge, with over 340,000 dropping coverage amid calls for price regulation and stronger public healthcare

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings